IMRX - Immuneering Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMRX is currently covered by 5 analysts with an average price target of $13.38. This is a potential upside of $9.2 (220.1%) from yesterday's end of day stock price of $4.18.

Immuneering Corp's activity chart (see below) currently has 14 price targets and 33 ratings on display. The stock rating distribution of IMRX is 8.7% HOLD and 91.3% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.22% with an average time for these price targets to be met of 35.89 days.

Highest price target for IMRX is $13, Lowest price target is $9, average price target is $10.5.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 18-Jun-2025. First documented stock forecast 24-Aug-2021.

Currently out of the existing stock ratings of IMRX, 2 are a HOLD (8.7%), 21 are a BUY (91.3%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$8.58 (194.12%)

$13

27 days ago
(18-Jun-2025)

0/7 (0%)

$10.23 (369.31%)

Buy

$9

$4.58 (103.62%)

$9

27 days ago
(18-Jun-2025)

0/8 (0%)

$6.23 (224.91%)

Hold

$1.5

$-2.92 (-66.06%)

$50

1 years 2 months 7 days ago
(08-May-2024)

1/2 (50%)

$-0.13 (-7.98%)

2

$4

$-0.42 (-9.50%)

$14

1 years 4 months 1 days ago
(14-Mar-2024)

2/4 (50%)

$1.1 (37.93%)

250

Buy

$25

$20.58 (465.61%)

$25

1 years 11 months 7 days ago
(08-Aug-2023)

0/3 (0%)

$15 (150.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMRX (Immuneering Corp) average time for price targets to be met?

On average it took 35.89 days on average for the stock forecasts to be realized with a an average price target met ratio 22.22

Which analyst has the current highest performing score on IMRX (Immuneering Corp) with a proven track record?

JEFFREY HUNG

Which analyst has the current lower performing score on IMRX (Immuneering Corp) with a proven track record?

MICHAEL YEE

Which analyst has the most public recommendations on IMRX (Immuneering Corp)?

Jeffrey Hung works at MORGAN STANLEY and has 6 price targets and 8 ratings on IMRX

Which analyst is the currently most bullish on IMRX (Immuneering Corp)?

Swapnil Malekar with highest potential upside - $33.32

Which analyst is the currently most reserved on IMRX (Immuneering Corp)?

Michael Yee with lowest potential downside - -$2.92

Immuneering Corp in the News

Immuneering (IMRX) chief people officer Neufeld buys $2498 in stock

Immuneering Corp (NASDAQ:IMRX) Chief People Officer Leah R. Neufeld reported purchasing 700 shares of Class A Common Stock on July 2, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were bought at a price of $3.5695, totaling $2498. The insider purchase comes as the stock has shown remarkable...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?